---
title: "Shen Lian Biomedical: Net loss of 12.8697 million yuan in the first half of 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255188601.md"
description: "Shen Lian Biomedical announced that its operating revenue in the first half of 2025 was 122 million yuan, a year-on-year decrease of 3.68%. The net loss attributable to shareholders of the listed company was 12.8697 million yuan, compared to a net loss of 34.508 million yuan in the same period last year"
datetime: "2025-08-29T11:23:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255188601.md)
  - [en](https://longbridge.com/en/news/255188601.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255188601.md)
generator: "portal-rs"
---

# Shen Lian Biomedical: Net loss of 12.8697 million yuan in the first half of 2025

Shen Lian Biomedical announced that its operating revenue in the first half of 2025 was 122 million yuan, a year-on-year decrease of 3.68%. The net loss attributable to shareholders of the listed company was 12.8697 million yuan, compared to a net loss of 34.508 million yuan in the same period last year

### Related Stocks

- [688098.CN](https://longbridge.com/en/quote/688098.CN.md)

## Related News & Research

- [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md)
- [14:41 ETNine Corboy & Demetrio Attorneys selected to 2027 The Best Lawyers in America®](https://longbridge.com/en/news/296644470.md)
- [LEAD Launch Leaves Accountable Care Technology Buyers Little Time for a Wrong Decision, Q3 Study](https://longbridge.com/en/news/296106866.md)
- [FONDIA: Profitability improved sharply in H1 2026, driven by growth in Finland and the Baltics](https://longbridge.com/en/news/296439068.md)
- [Guolian Minsheng Securities files board, committee member list and disclosure-responsible management roster](https://longbridge.com/en/news/296613261.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**